These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
468 related items for PubMed ID: 15492946
21. Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial. Ruilope LM, Zanchetti A, Julius S, McInnes GT, Segura J, Stolt P, Hua TA, Weber MA, Jamerson K, VALUE Investigators. J Hypertens; 2007 Jul; 25(7):1473-9. PubMed ID: 17563571 [Abstract] [Full Text] [Related]
22. [Progression of renal insufficiency in the pre-end-stage renal disease setting]. Caravaca F, Arrobas M, Luna E, Pizarro JL, García C, Espárrago JF, Sánchez-Casado E. Nefrologia; 2003 Jul; 23(6):510-9. PubMed ID: 15002786 [Abstract] [Full Text] [Related]
23. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Hsu CY, McCulloch CE, Darbinian J, Go AS, Iribarren C. Arch Intern Med; 2005 Apr 25; 165(8):923-8. PubMed ID: 15851645 [Abstract] [Full Text] [Related]
24. Predictors of end-stage renal disease and body mass index in a screened cohort. Iseki K, Ikemiya Y, Fukiyama K. Kidney Int Suppl; 1997 Dec 25; 63():S169-70. PubMed ID: 9407450 [Abstract] [Full Text] [Related]
25. Blood pressure and risk of end-stage renal disease in a screened cohort. Iseki K, Ikemiya Y, Fukiyama K. Kidney Int Suppl; 1996 Jun 25; 55():S69-71. PubMed ID: 8743514 [Abstract] [Full Text] [Related]
26. Atherosclerotic risk factors and renal function in the elderly: the role of hyperfibrinogenaemia and smoking. Results from the Italian Longitudinal Study on Ageing (ILSA). Baggio B, Budakovic A, Perissinotto E, Maggi S, Cantaro S, Enzi G, Grigoletto F, ILSA Working Group. Nephrol Dial Transplant; 2005 Jan 25; 20(1):114-23. PubMed ID: 15572387 [Abstract] [Full Text] [Related]
27. Calculated versus measured creatinine clearance for dosing methotrexate in the treatment of primary central nervous system lymphoma. Gerber DE, Grossman SA, Batchelor T, Ye X. Cancer Chemother Pharmacol; 2007 May 25; 59(6):817-23. PubMed ID: 16972068 [Abstract] [Full Text] [Related]
28. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia. Jeffres MN, Isakow W, Doherty JA, Micek ST, Kollef MH. Clin Ther; 2007 Jun 25; 29(6):1107-15. PubMed ID: 17692725 [Abstract] [Full Text] [Related]
29. Effectiveness of furosemide in patients on peritoneal dialysis. Flinn A, Ledger S, Blake P. CANNT J; 2006 Jun 25; 16(3):40-4. PubMed ID: 17061696 [Abstract] [Full Text] [Related]
30. Risk factors of renal failure progression two years prior to dialysis. Mazouz H, Kacso I, Ghazali A, El Esper N, Moriniere P, Makdassi R, Hardy P, Westeel PF, Achard JM, Pruna A, Fournier A. Clin Nephrol; 1999 Jun 25; 51(6):355-66. PubMed ID: 10404696 [Abstract] [Full Text] [Related]
31. Comparison of estimated glomerular filtration rate with estimated creatinine clearance in the dosing of drugs requiring adjustments in elderly patients with declining renal function. Spruill WJ, Wade WE, Cobb HH. Am J Geriatr Pharmacother; 2008 Aug 25; 6(3):153-60. PubMed ID: 18775390 [Abstract] [Full Text] [Related]
32. Proteinuria and the risk of developing end-stage renal disease. Iseki K, Ikemiya Y, Iseki C, Takishita S. Kidney Int; 2003 Apr 25; 63(4):1468-74. PubMed ID: 12631363 [Abstract] [Full Text] [Related]
33. Genomewide linkage analysis to serum creatinine, GFR, and creatinine clearance in a community-based population: the Framingham Heart Study. Fox CS, Yang Q, Cupples LA, Guo CY, Larson MG, Leip EP, Wilson PW, Levy D. J Am Soc Nephrol; 2004 Sep 25; 15(9):2457-61. PubMed ID: 15339995 [Abstract] [Full Text] [Related]
34. Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan. Hwang SJ, Lin MY, Chen HC, Hwang SC, Yang WC, Hsu CC, Chiu HC, Mau LW. Nephrol Dial Transplant; 2008 Oct 25; 23(10):3192-8. PubMed ID: 18450830 [Abstract] [Full Text] [Related]
35. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study. Manno C, Strippoli GF, D'Altri C, Torres D, Rossini M, Schena FP. Am J Kidney Dis; 2007 Jun 25; 49(6):763-75. PubMed ID: 17533019 [Abstract] [Full Text] [Related]
36. Kidney function and cardiovascular disease in the hypertensive population: the ERIC-HTA study. Redón J, Cea-Calvo L, Lozano JV, Fernández-Pérez C, Navarro J, Bonet A, González-Esteban J, ERIC-HTA 2003 Study Investigators. J Hypertens; 2006 Apr 25; 24(4):663-9. PubMed ID: 16531794 [Abstract] [Full Text] [Related]
37. [Survey of risk factors and renal disease in first-degree relatives of dialysis patients]. Inserra F, de la Llave G, Alpino M, Castagna R, de la Fuente I, Dorado E, Norbis M, Pinelli L, Puddu M, Santos JC, Vivas N, Marelli C. Medicina (B Aires); 2007 Apr 25; 67(1):8-18. PubMed ID: 17408015 [Abstract] [Full Text] [Related]
38. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis. Onuigbo MA, Onuigbo NT. QJM; 2008 Jul 25; 101(7):519-27. PubMed ID: 18375475 [Abstract] [Full Text] [Related]
39. Creatinine clearance, cystatin C, beta2-microglobulin and TATI as markers of renal function in patients with proteinuria. Tramonti G, Cipollini I, Annichiarico C, Lorusso P, Panicucci E, Mariani G, Barsotti G. J Nephrol; 2012 Jul 25; 25(6):976-82. PubMed ID: 22307441 [Abstract] [Full Text] [Related]
40. SCreening for Occult REnal Disease (SCORED): a simple prediction model for chronic kidney disease. Bang H, Vupputuri S, Shoham DA, Klemmer PJ, Falk RJ, Mazumdar M, Gipson D, Colindres RE, Kshirsagar AV. Arch Intern Med; 2007 Feb 26; 167(4):374-81. PubMed ID: 17325299 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]